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Type 2 diabetes mellitus red zoneMapping type 2 diabetes mellitus in the whole globe is both
interesting and striking when looking at the actual number of af-
fected people with type 2 diabetes mellitus. Calculating the num-
ber of diabetic patients using the prevalence of this disease and
the total number of targeted population of any given community,
provides a good estimate of the number of people affected by the
disease. More than 50% of the global number of diabetic patients
inhabit a speciﬁc geographical area. This area is located in the
northern tropical zone, involving North Africa, and the southwest,
southern, southeast and eastern part of Asia. It could be labeled as
a type 2 diabetes mellitus red zone, which has variable human and
land geography. The diabetes red zone occupies less than 20% of
the total land global surface area, but at the same time, is inhabited
by more than 50% of the total human population [1].
Geographically, the type 2 diabetes red zone is variable, ranging
from dry desert areas to heavily raining green land. At the same
time, it has the lowest level below sea and the highest mountains
above sea level. This area is also unique for its wide cultural, social
and ethnic variations. This makes the diabetes red zone area a po-
sitive research ﬁeld for both the geographical and cultural impact
of the disease.
There is enough epidemiological data to support the fact that
type 2 diabetes has a different presence in different populations
that are reﬂected by the incidence of the disease and its preva-1877-5934  2009 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
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Olence. These could be attributed to different risk factors that affect
any given population. Ethnicity, family history and ageing are
unavoidable factors, all of which contribute to the high diabetes
prevalence in certain populations [2]. Lifestyle change in both
developed and developing countries, namely globalization, has
had an effect on diabetes prevalence, which is associated with high
calorie intake, low physical exercise and obesity. Further studies
have conﬁrmed the continuous increase in diabetes prevalence in
every country, with a variable ﬁgure ranging between 1.4% in rural
Vietnam [3] and 70% among Pima Indians in United States [4].
WHO studied the rising prevalence of diabetes mellitus and im-
paired glucose tolerance based on 75 communities in 32 countries
[5] and it is time now for further studies that link the global diabe-
tes database to the status of human health, and its burden on world
economy.
A population based surveys of the type 2 diabetes red zone
would give the greatest chance to study the role of different risk
factors that has been linked to the raising type 2 diabetes preva-
lence. There is enough scientiﬁc evidence to link urbanization to
an increase of type 2 diabetes mellitus, regardless of the country’s
ﬁnancial status. There are many poor developing countries in this
red zone that are affected by globalization and have demonstrated
an increase in the incidence of this disease. This has been exacer-
bated by the new global increase of type 2 diabetes mellitus amongpen access under CC BY-NC-ND license.
Table 1
The top 10 countries for type 2 diabetes mellitus, according to the number and
prevalence for people aged between 20 and 79 years in the year 2007 and 2025.
Source: Diabetes Atlas Third Edition, International Diabetes Federation (IDF) – 2006.
2007 2025
Patients
(millions)
Prevalence (%) Patients
(millions)
Prevalence (%)
1 India (40.9) Nauru (30.7) India (69.9) Nauru (32.3)
2 China (39.8) UAE (19.5) China (59.3) UAE (21.9)
3 USA (19.2) Saudi Arabia
(16.7)
USA (25.4) Saudi Arabia
(18.4)
4 Russia (9.6) Bahrain (15.2) Brazil (17.6) Bahrain (17.0)
5 Germany (7.4) Kuwait (14.4) Pakistan (11.5) Kuwait (16.4)
6 Japan (7.0) Oman (13.1) Mexico (10.8) Tonga (15.2)
7 Pakistan (6.9) Tonga (12.9) Russia (10.3) Oman (14.7)
8 Brazil (6.9) Mauritius (11.1) Germany (8.1) Mauritius (13.4)
9 Mexico (6.1) Egypt (11.0) Egypt (7.6) Egypt (13.4)
10 Egypt (4.4) Mexico (10.6) Bangladesh
(7.4)
Mexico (12.4)
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change in lifestyle in the form of high calorie dietary intake and
low physical activity in that age group [6].
The International Diabetes Federation (IDF) has produced a doc-
ument listing the top 10 countries in terms of number of people
with diabetes aged 20–79 years. This shows 5 out of 10 countries
to be from the red zone, namely India, China, Japan, Pakistan and
Egypt. These ﬁve countries contributed to 94.6% of the total num-
ber of people with diabetes among the top 10. It is anticipated that
by 2025, Bangladesh will join the top 10 countries, replacing Japan.
But when looking at the top 10 countries in terms of prevalence of
diabetes, eight countries are located in the red zone area, namely
Nauru, United Arab Emirates, Saudi Arabia, Bahrain, Kuwait, Oman,
Tonga and Egypt. These countries will remain the top in year 2025.
Table 1 shows the top 10 countries, according to the number of
diabetic patients and the prevalence of diabetes, which compare
data from the year 2007 with expected changes in the year 2025.
Although India and China are inhabited by the largest number of
diabetic patients (80.7 millions) as a result of their large popula-
tion size, neither country appeared in the top 10 countries when
diabetes prevalence was looked at. When looking to the highest
prevalence of diabetes mellitus in the top 10 countries, six coun-
tries are from the Arab World (i.e., Middle East), but ﬁve of them
are from the gulf countries, namely the United Arab Emirates, Sau-
di Arabia, Bahrain, Kuwait, and Oman. Gulf States have a higher
prevalence rate than other Middle East countries such as Egypt.
This observation provides a strong clue that Arab Ethnicity is at a
higher risk of developing type 2 diabetes mellitus and that popula-
tions from Gulf States are the highest. It is anticipated that these
countries will continue to be among the top 10 countries in the
year 2025.
The type 2 diabetes red zone could now be easily divided into
two parts: the eastern part, which has the largest number of dia-
betic patients but with a prevalence rate of less than 10%; and
the western part, which has the highest diabetes prevalence (more
than 10%) but a smaller number of diabetic patients, due to their
small population size. The western part consists of Middle Eastern
countries, which are inhabited mainly by Arab Ethnicity. The
Republic of Nauru, an Island in the South Paciﬁc, has the highestglobal prevalence rate of type 2 diabetes, but is only inhabited by
12,000 people with different ethnicities, according to a United Na-
tions estimation.
There are numerous global studies that link ethnicity to type 2
diabetes susceptibility, regardless of environmental factors. Stud-
ies have proved that even with equal lifestyle changes, the preva-
lence of type 2 diabetes mellitus differs between people with
different ethnicity, regardless of their geographical location. Jenum
et al. have demonstrated the high prevalence of diabetes among
South Asian women in Norway after adjustment for age, adiposity,
physical activity and education that could be explained by ethnic-
ity [7]. Asian Americans and Paciﬁc Islanders have also been found
to be signiﬁcantly more at risk of developing type 2 diabetes than
non-Hispanic whites [8]. These scientiﬁc clues may mean that the
ethnicity of people from the red zone has a special effect on type 2
diabetes etiology. Tan et al. have shown the effect of ethnicity be-
tween Chinese, Malay and Indians in Singapore for type 2 diabetes,
especially among females [9], which conﬁrms the ethnicity effect
within the red zone geographical location.
Arabs who could be considered an ethnicity with high fre-
quency for type 2 diabetes have demonstrated the high prevalence
in the Middle East, and also as an immigrant to different parts of
the world, as shown in different studies [10].
The red zone for type 2 diabetes relates to high prevalence or
large population, and warrants more study and a better focus when
ﬁghting this disease and its complications globally. This area is also
expected to have more than 50% of mortality and morbidity from
this disease. Half of the global economic impact of type 2 diabetes
is from this area. This geographical area thus needs more attention
when considering prevention programs and drugs supply.
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